Filtros de búsqueda

Lista de obras de Peter Laszlo Lakatos

'Treat to Target' - Lessons Learnt

artículo científico publicado en 2016

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations

artículo científico publicado en 2016

A budget impact model for biosimilar infliximab in Crohn's disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia

artículo científico publicado en 2015

A felső és alsó endoszkópiák indikációja, a diagnózisok megoszlása és minőségi mutatók 2010–2011-ben a Semmelweis Egyetem I. Belgyógyászati Klinikáján

article published in 2016

A review of mortality and surgery in ulcerative colitis: milestones of the seriousness of the disease.

artículo científico publicado en 2013

A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes

artículo científico publicado en 2022

Access to biologicals in Crohn's disease in ten European countries

artículo científico publicado en 2017

Accuracy of amplitude-integrated electroencephalography in the prediction of neurodevelopmental outcome in asphyxiated infants receiving hypothermia treatment

artículo científico publicado en 2013

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: a systematic review and meta-analysis

artículo científico publicado en 2014

Adenomatous polyps in ulcerative colitis and colonic Crohn's disease: less frequent, but does this change surveillance strategy?

artículo científico publicado en 2016

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature

artículo científico publicado en 2014

Anti-TNF dose escalation and drug sustainability in Crohn's disease: Data from the nationwide administrative database in Hungary

scientific article published on 24 October 2019

Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?

artículo científico publicado en 2011

Anti-TNF-alpha therapy in ulcerative colitis

artículo científico publicado en 2008

Anti-TNFs and severe infections in autoimmune diseases: The other side of the coin ⬇️

artículo científico publicado el 8 de junio de 2012

Anti-microbial antibodies in celiac disease: trick or treat?

artículo científico publicado en 2009

Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

artículo científico publicado en 2014

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort

artículo científico publicado en 2010

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

artículo científico publicado en 2018

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

scientific article published on 15 April 2020

Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease

artículo científico publicado en 2008

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

artículo científico publicado en 2016

Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.

artículo científico publicado en 2014

Azathioprine in Early Crohn’s Disease: Time to Revisit Patient Selection and End Points for Clinical Trials and/or Azathioprine Efficacy?

Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease

artículo científico publicado en 2015

Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe

artículo científico publicado en 2015

Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.

artículo científico publicado en 2016

Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?

artículo científico publicado en 2019

Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation

artículo científico publicado en 2016

Biosimilars in ulcerative colitis: When and for who?

scholarly article by Akos Ilias et al published February 2018 in Best Practice and Research: Clinical Gastroenterology

Bone Homeostasis in Intestinal Disorders

Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe

artículo científico publicado en 2015

Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?

scientific article published on 01 September 2019

Can we predict disease course with clinical factors?

artículo científico publicado en 2017

Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study

artículo científico publicado en 2011

Challenges in Calculating the Risk for Colorectal Cancer in Patients With Ulcerative Colitis ⬇️

artículo científico publicado el 18 de mayo de 2012

Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy.

artículo científico publicado en 2007

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

artículo científico publicado en 2015

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review

scientific article published on 21 December 2018

Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?

artículo científico publicado en 2013

Clinical relevance of changes in bone metabolism in inflammatory bowel disease

artículo científico publicado en 2010

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

artículo científico publicado en 2009

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients

artículo científico publicado en 2007

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn's Disease

artículo científico publicado en 2017

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

artículo científico publicado en 2009

Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe

artículo científico publicado en 2011

Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe.

artículo científico publicado en 2017

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications

scientific article published on 05 November 2021

Current Concepts on the Genetics and Pharmacogenetics of Inflammatory Bowel Disease: Do they Help in Clinical Management?

article

Current status of thiopurine analogues in the treatment in Crohn's disease.

artículo científico publicado en 2011

Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of an index to define overall disease severity in IBD.

artículo científico publicado en 2016

Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.

artículo científico publicado en 2014

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

artículo científico publicado en 2016

Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study

scientific article published on 21 January 2019

Does Hospitalization Predict the Disease Course in Ulcerative Colitis? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Ulcerative Colitis in a Population-based Inception Cohort (2000-2012).

artículo científico publicado en 2015

Does dermatitis herpetiformis result in bone loss as coeliac disease does?: a cross sectional study

artículo científico publicado en 2013

Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.

artículo científico publicado en 2013

Double balloon enteroscopy examinations in general anesthesia

artículo científico publicado en 2010

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.

artículo científico publicado en 2012

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases.

artículo científico

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

artículo científico publicado en 2016

Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors’ reply

artículo científico publicado en 2018

Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator?

artículo científico publicado en 2017

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

artículo científico publicado en 2008

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort

artículo científico publicado en 2015

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe--a Hungarian nationwide observational study

artículo científico publicado en 2009

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.

artículo científico publicado en 2016

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

artículo científico publicado en 2015

Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape

artículo científico publicado en 2019

Elevated plasma nociceptin level in patients with Wilson disease

artículo científico publicado en 2002

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis

artículo científico publicado en 2000

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in patients with primary biliary cirrhosis

artículo científico publicado en 1999

Enteroscopy in small-bowel Crohn's disease (CD): hypes and hopes.

artículo científico publicado en 2014

Environment and invironment in IBDs: partners in crime

Environmental factors affecting inflammatory bowel disease: have we made progress?

artículo científico publicado en 2009

Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016

scientific article published on 28 January 2020

Epidemiology of inflammatory bowel diseases from west to east

artículo científico publicado en 2017

European Experience of Infliximab Biosimilars for the Treatment of Inflammatory Bowel Disease

artículo científico publicado en 2016

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

article

Evaluation of the combined application of ethanol-fixed and formaldehyde-fixed neutrophil substrates for identifying atypical perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease

artículo científico publicado en 2009

Evidence or eminence: optimising patient outcomes by choosing the right doctor?

artículo científico publicado en 2012

Extraintestinal Manifestations of Inflammatory Bowel Disease.

artículo científico publicado en 2015

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis

artículo científico publicado en 2020

Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease

artículo científico publicado en 2013

Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy

artículo científico publicado en 2014

General anesthesia during double balloon enteroscopy--Hungarian experiences

artículo científico publicado en 2010

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease

artículo científico publicado en 2013

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

artículo científico publicado en 2017

Haptoglobin Polymorphism: A Novel Genetic Risk Factor for Celiac Disease Development and Its Clinical Manifestations

article

Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in Hungarian patients.

artículo científico publicado en 2007

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic

scientific article published on 03 December 2018

Have biologics changed the natural history of Crohn's disease?

artículo científico

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study

artículo científico publicado en 2014

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study

article

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance

artículo científico publicado en 2019

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

artículo científico publicado en 2013

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival

artículo científico publicado en 2018

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification? ⬇️

artículo científico publicado el 13 de noviembre de 2011

Hospitalisations and surgery in Crohn's disease

artículo científico

IBD in 2016: Biologicals and biosimilars in IBD - the road to personalized treatment.

artículo científico publicado en 2017

IBD in the elderly population: Results from a population-based study in Western Hungary, 1977–2008 ⬇️

artículo científico publicado el 15 de septiembre de 2010

Immune dysfunction in cirrhosis

artículo científico

Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease

artículo científico publicado en 2010

Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.

artículo científico publicado en 2013

Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

artículo científico publicado en 2014

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center

artículo científico publicado en 2017

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicentre observational cohort

artículo científico publicado en 2018

Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.

artículo científico publicado en 2012

Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort

artículo científico publicado en 2013

Is the disease course predictable in inflammatory bowel diseases?

artículo científico publicado en 2010

Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?

artículo científico publicado en 2009

Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD?

artículo científico publicado en 2010

Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines

artículo científico publicado en 2014

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.

artículo científico publicado en 2018

Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center

scientific article published on 07 December 2019

Low bone mass in microscopic colitis ⬇️

artículo científico publicado en 2011

Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort

artículo científico publicado en 2014

Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.

artículo científico publicado en 2012

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease

artículo científico publicado en 2019

Management of Acute Severe Colitis in the Era of Biologicals and Small Molecules

scientific article published on 08 December 2019

Management of inflammatory bowel diseases: a changing paradigm. Can we finally change the disease course?

artículo científico publicado en 2010

Manipulating bone disease in inflammatory bowel disease patients

artículo científico publicado en 2013

Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis

artículo científico publicado en 2010

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort

artículo científico publicado en 2010

Methotrexate: should we start using it in clinical practice?

artículo científico publicado en 2013

Mucosal healing with anti-TNF antibodies

artículo científico

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database

artículo científico publicado en 2016

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study

scientific article published on 01 February 2019

Natural history of ulcerative colitis: current knowledge

artículo científico publicado en 2011

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

artículo científico publicado en 2008

New serological markers in pediatric patients with inflammatory bowel disease

artículo científico

New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe

artículo científico publicado en 2012

Nonadherence in inflammatory bowel disease: results of factor analysis

artículo científico publicado en 2007

Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease.

artículo científico publicado en 2007

Nutritional influences in selected gastrointestinal diseases

artículo científico publicado en 2011

Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?

scientific article published on 28 August 2008

Optimizing Patient Management in Crohn's Disease in a Tertiary Referral Center: the Impact of Fast-Track MRI on Patient Management and Outcomes

artículo científico publicado en 2018

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

scientific article published on 08 January 2019

Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease.

artículo científico publicado en 2012

Patient and general population values for luminal and perianal fistulising Crohn's disease health states

scientific article published on 17 May 2019

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre

scientific article published on 01 September 2019

Perceived Risks Contra Benefits of Using Biosimilar Drugs in Ulcerative Colitis: Discrete Choice Experiment among Gastroenterologists.

artículo científico publicado en 2016

Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis

artículo científico publicado en 2011

Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme.

artículo científico publicado en 2011

Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus

artículo científico publicado en 2020

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases

artículo científico publicado en 2018

Postoperative recurrence of Crohn's disease, and its prevention

artículo científico publicado en 2010

Prediction of disease course in inflammatory bowel diseases

artículo científico publicado en 2010

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

artículo científico publicado en 2012

Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy.

artículo científico publicado en 2013

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study

artículo científico publicado en 2010

Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

artículo científico publicado en 2010

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012

artículo científico publicado en 2015

Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?

artículo científico publicado en 2009

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

artículo científico publicado en 2015

Progress with infliximab biosimilars for inflammatory bowel disease.

artículo científico publicado en 2018

Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

artículo científico publicado en 2018

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies

artículo científico publicado en 2017

Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab.

artículo científico publicado en 2017

Recommendations for identifying Crohn's disease patients with poor prognosis

artículo científico publicado en 2013

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

artículo científico publicado en 2015

Reply

Reply to Letter on: "Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis"

artículo científico publicado en 2019

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease

artículo científico

Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies.

artículo científico publicado en 2015

Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

scientific article published on 01 January 2019

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease.

artículo científico publicado en 2015

Risk factors for complications in patients with ulcerative colitis

artículo científico publicado en 2016

Risk of Malignant Cancers in Inflammatory Bowel Disease

artículo científico publicado en 2019

Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography

artículo científico publicado en 2019

Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.

artículo científico publicado en 2015

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

artículo científico

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

artículo científico publicado en 2019

Serologic antiglycan antibodies in inflammatory bowel disease.

artículo científico publicado en 2011

Serological studies in inflammatory bowel disease: how important are they?

artículo científico publicado en 2014

Serum anti-Saccharomyces cerevisiae antibodies in Greek patients with Behcet's disease

artículo científico publicado en 2011

Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs disease ⬇️

artículo científico publicado el 23 de septiembre de 2010

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

artículo científico publicado en 2018

Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease.

artículo científico publicado en 2017

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease

artículo científico publicado en 2015

The IL-10R1 S138G loss-of-function allele and ulcerative colitis.

artículo científico publicado en 2008

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study.

artículo científico publicado en 2017

The Use of Balloon-assisted Enteroscopy at a Large Volume Centre: A Retrospective Analysis

scientific article published on 27 March 2018

The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method.

scientific article published on 17 September 2013

The natural history of Crohn's disease in children: a review of population-based studies

artículo científico publicado en 2016

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern Europe ⬇️

artículo científico publicado el 4 de julio de 2012

Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab

artículo científico publicado en 2018

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

artículo científico publicado en 2018

Therapy of steroid-resistant inflammatory bowel disease

artículo científico publicado en 2012

Thiopurines in Crohn's disease, is there something new?

artículo científico publicado en 2010

Treatment of extraintestinal manifestations in inflammatory bowel disease

artículo científico

Treatment preferences of originator versus biosimilar drugs in Crohn's disease; discrete choice experiment among gastroenterologists

artículo científico publicado en 2015

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

artículo científico publicado en 2019

Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease

artículo científico publicado en 2015

Ulcerative proctitis: a review of pharmacotherapy and management

artículo científico publicado en 2008

Ulcerative proctitis: an update on the pharmacotherapy and management

artículo científico

Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?

artículo científico publicado en 2009

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

scientific article published on 17 September 2018

Ver(s)ifying the Efficacy of Vedolizumab Therapy on Mucosal Healing in Patients With Crohn's Disease

artículo científico publicado en 2019

Vitamin D level in Hungarian patients with inflammatory bowel diseases

artículo científico publicado en 2013

Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis

artículo científico publicado en 2002

Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

artículo científico publicado en 2014

[Crohn's disease of the duodenum. Clinical signs, diagnosis, conservative and surgical treatment]

artículo científico publicado en 2008

[Epidemiology, predictors and clinical aspects of loss of response to biological therapy]

artículo científico publicado en 2012

[Prediction of the disease course in inflammatory bowel diseases]

scientific article published on 01 February 2010

[Relevance of serologic studies in inflammatory bowel diseases]

artículo científico publicado en 2007

[The diagnostics of osteoporosis in the evaluation of fracture risk]

artículo científico publicado en 2006

[The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases]

artículo científico publicado en 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda